We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-7.45%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$549M
AUM Growth
-$91.5M
Cap. Flow
-$50.6M
Cap. Flow %
-9.22%
Top 10 Hldgs %
42.34%
Holding
105
New
18
Increased
27
Reduced
20
Closed
23

Top Buys

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$9.69M
2
CYTK icon
Cytokinetics
CYTK
+$7.79M
3
AMD icon
Advanced Micro Devices
AMD
+$5.25M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$4.87M
5
PMN icon
ProMIS Neurosciences
PMN
+$4.77M

Top Sells

Rank Stock Value
1
NICE icon
Nice
NICE
+$9.95M
2
NVMI
Nova
NVMI
+$8.21M
3
CAMT icon
Camtek
CAMT
+$6.75M
4
SAGE
Sage Therapeutics
SAGE
+$6.02M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$5.29M

Sector Composition

Rank Sector Weight
1 Healthcare 60.67%
2 Technology 7.83%
3 Consumer Discretionary 2.21%
4 Communication Services 0.83%
5 Materials 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
76
Cartesian Therapeutics
RNAC
$229M
$797K 0.15%
25,071
-42,879
-63% -$1.43M
APGE icon
77
Apogee Therapeutics
APGE
$10.1B
$639K 0.12%
+30,000
New +$661K
ELEV
78
DELISTED
Elevation Oncology
ELEV
$596K 0.11%
900,000
– –
VTGN icon
79
VistaGen Therapeutics
VTGN
$9.89M
$524K 0.1%
+100,000
New +$444K
IMTXW
80
DELISTED
Immatics N.V. Warrants
IMTXW
$354K 0.06%
100,000
– –
CALT
81
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$217K 0.04%
+11,863
New +$205K
ACLX
82
DELISTED
Arcellx
ACLX
– –
-77,488
Closed -$2.45M
ALT icon
83
Altimmune
ALT
$552M
– –
-500,000
Closed -$1.76M
AMD icon
84
CALL
Advanced Micro Devices
AMD
$776B
– –
-120,000
Closed -$13.7M
ARBE icon
85
Arbe Robotics
ARBE
$80.3M
– –
-43,165
Closed -$125K
ARGX icon
86
PUT
argenx
ARGX
$54.6B
– –
-10,000
Closed -$3.9M
BBIO icon
87
CALL
BridgeBio Pharma
BBIO
$15.7B
– –
-130,000
Closed -$2.24M
CAMT icon
88
Camtek
CAMT
$6.18B
– –
-189,494
Closed -$6.75M
BGMS
89
Bio Green Med Solution Inc
BGMS
$4.91M
– –
-69
Closed -$147K
DYN icon
90
Dyne Therapeutics
DYN
$4.7B
– –
-119,918
Closed -$1.35M
ENLT icon
91
Enlight Renewable Energy
ENLT
$11.8B
– –
-211,586
Closed -$3.76M
ENPH icon
92
CALL
Enphase Energy
ENPH
$4.96B
– –
-40,000
Closed -$6.7M
GNRC icon
93
CALL
Generac Holdings
GNRC
$11.6B
– –
-52,500
Closed -$7.83M
MRSN
94
DELISTED
Mersana Therapeutics
MRSN
– –
-16,742
Closed -$1.38M
MSFT icon
95
CALL
Microsoft
MSFT
$3.45T
– –
-21,000
Closed -$7.15M
NVMI
96
Nova
NVMI
$12.4B
– –
-70,000
Closed -$8.21M
PMVP icon
97
PMV Pharmaceuticals
PMVP
$59.2M
– –
-187,800
Closed -$1.18M
QCOM icon
98
Qualcomm
QCOM
$155B
– –
-32,000
Closed -$3.81M
SAGE
99
DELISTED
Sage Therapeutics
SAGE
– –
-128,000
Closed -$6.02M
SRPT icon
100
CALL
Sarepta Therapeutics
SRPT
$1.57B
– –
-78,300
Closed -$8.97M
1 2 3
4
5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sphera Funds Management held 105 positions worth $549M, down 14% from $640M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management withdrew a net $50.6M in Q3 2023, closing 23 positions and reducing 20 holdings. Its most notable exit was Nova, an estimated $8.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Cytokinetics worth $6.89M.

  • Sphera Funds Management's largest Q3 2023 buy was Cytokinetics: 233,933 shares worth $6.89M.
  • Sphera Funds Management added most to Tower Semiconductor in Q3 2023, an estimated $9.69M increase.
  • Sphera Funds Management's biggest Q3 2023 reduction was Nice, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Nova in Q3 2023, selling an estimated $8.21M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $549M portfolio in Q3 2023.
  • Sphera Funds Management opened 18 new positions and closed 23 in Q3 2023.
  • Sphera Funds Management's portfolio value fell 14% quarter-over-quarter to $549M.

Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.